Good morning, Chair and members of the committee. I am the clinical director of the national women and infants health programme, NWIHP. I thank the committee for the invitation to join its meeting this morning to discuss termination of pregnancy services, and in particular, the mandatory three-day waiting period provided for under the Health (Regulation of Termination of Pregnancy) Act. I welcome the committee’s consideration of this important issue. I am joined by my colleague Dr. Aoife Mullally, national clinical lead for termination of pregnancy services.
Since the commencement of the current legislative framework in 2019, termination of pregnancy services has evolved into an integrated and integral part of women’s healthcare. Safe, high-quality termination of pregnancy care is an essential element of the healthcare services we provide, and we remain committed to ensuring women can access these services in a timely, safe and equitable manner. There has been important progress in the provision of termination of pregnancy services nationally. The number of units providing these services increased from ten in 2019 to 19 in 2025, each with designated clinical leads and termination of pregnancy service co-ordinators. In primary care, the number of GP providers holding contracts has increased from 281 in 2019 to 498 currently.
Governance has also been strengthened through the national women and infants health programme, NWIHP, and the national termination of pregnancy service improvement group. Substantial work is under way on education and training, audit and data collection, guideline revision and the development of patient information resources, including the recently published Termination of Pregnancy - Guide to the 2018 Legislation and Termination of Pregnancy for Fetal Anomaly, which provides support, information and guidance to women and families considering a termination of pregnancy for foetal anomaly. These developments reflect the significant work undertaken by the HSE, healthcare professionals and service providers to establish and expand termination of pregnancy services across the country. This work extends beyond access alone, encompassing the delivery of safe, accessible and high-quality care underpinned by strong clinical governance, evidence-based practice, education and training, quality improvement, robust data and audit and clear, accessible information and support for women and their families. Together, these elements are central to ensuring services are delivered consistently and safely within the legislative and clinical framework.
Under current legislation, termination of pregnancy is a legal entitlement. The HSE’s role is to support the delivery of services within the agreed legislative and policy framework, working with healthcare professionals, service providers and relevant colleagues across the system to ensure that women receive appropriate information, care and support throughout their care pathway. As the service continues to develop, the HSE also brings operational and clinical experience to its engagement with the Department of Health and other relevant stakeholders, supporting the implementation of agreed policy and contributing to the continued development and improvement of services.
Today, the committee is considering the operation and implications of the mandatory three-day waiting period. At the outset, I would like to state that any decision on the potential removal of the three-day waiting period is a matter for policy and, ultimately, for the Oireachtas. However, from a clinical and operational perspective, the HSE has no fundamental objection to its removal. The current model of care for termination of pregnancy services has been developed and implemented within the existing legislative framework, including the mandatory period. As a result, appointment scheduling, referral pathways, workforce planning, service configuration and administration have developed around this requirement. Any change would therefore require some consideration and planning to ensure the transition is managed effectively and that services continue to operate safely and consistently.
From a clinical perspective, the HSE’s position is that there is no clinical requirement for a mandatory three-day waiting period or for any period beyond the time necessary for a woman to consider and absorb the information provided as part of the consultation and informed consent process. However, there is an important distinction between removing a mandatory waiting period and removing the opportunity for reflection. Some women may value additional time to consider their decision and that opportunity should remain available to them. Removing a mandatory waiting period would not mean every woman would necessarily proceed to treatment on the day of consultation. The timing of care would continue to depend on the individual woman’s circumstances, clinical assessment, service arrangements and, importantly, her own wishes. What would change is that additional time for reflection would be available as a matter of choice rather than imposed as a mandatory requirement. This is consistent with a more flexible, patient-centred approach based on informed consent, autonomy and individualised decision-making. It also recognises that women accessing abortion services will have different circumstances, needs and preferences.
The HSE has not undertaken a dedicated review of service user feedback specifically on the mandatory waiting period. However, the evidence available from the Unplanned Pregnancy and Abortion Care,UnPAC, study and other research supports consideration of greater flexibility within the existing model of care.
The UnPAC study commissioned as part of the review of the Health (Regulation of Termination of Pregnancy) Act explored the experiences of individuals accessing abortion services under section 12 of the Act. The study found that the mandatory waiting period was a recurring feature of discussions across the majority of interviews. Participants expressed a range of views. Some regarded the waiting period as a procedural requirement that had to be navigated, while others experienced it as a barrier or unnecessary delay. Very few participants considered the waiting period to have been beneficial to their own decision-making process, although some acknowledged that other women might value additional time for reflection.
The study found support for a more flexible approach, where women could access treatment without a mandatory waiting period while retaining the option of additional consultation where this was desired and agreed with the provider. The UnPAC report noted that women are generally clear on their decision and are anxious for timely access, which is at odds with the mandatory three-day waiting period.
Mandatory waiting is not a universal feature of abortion care internationally. Several jurisdictions, including France and the Netherlands, have recently moved away from mandatory periods towards a reliance on standard informed consent processes. Importantly, the WHO safe abortion guidance also recommends against mandatory waiting periods, identifying them as potential barriers to access and recognition of women as competent decision-makers.
At the same time, removal of the mandatory waiting period would require some consideration of practical implications. The existing pathway operates through separate stages of assessment, certification and treatment. A revised model would need to provide clarity on how the stages would operate, including whether assessment and treatment could take place during the same consultation, how appointments would be scheduled and how an optional period of reflection could be accommodated for women who wish to take additional time.
As is the case across other areas of healthcare, we believe women should have the opportunity to take additional time for reflection where they wish to do so. We do not consider that there is a clinical rationale for a mandatory three-day waiting period where a woman has made an informed decision to proceed. Again, that does not mean that a termination would necessarily take place on the same day, as the timing of care will continue to depend on the individual woman's circumstances, clinical assessment, service arrangements and wishes. The key distinction is the opportunity for additional reflection should be available to a woman who wants it rather than imposed as a mandatory requirement on every woman.
The HSE will continue to support the delivery of safe and accessible and high-quality termination of pregnancy services within the agreed legislative and policy framework, working closely with the Department of Health, policy units and relevant stakeholders and bringing the operational and clinical expense of the health service to ongoing policy consideration. I thank the committee for its time.